pfizer 3sbio - Search News

News

Pfizer Strikes Deal With China's 3SBio

Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China

Key Takeaways Pfizer said late Monday that it has agreed to a deal to help develop and market a Chinese cancer drug across the globe.Chinese firm 3SBio is developing a drug that is in trials to treat several forms of cancer,

· 21h · on MSN

· 19h

Pfizer Thinks Bigger With 3SBio Deal

· 1d · on MSN

Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake

PharmExec17h

Pfizer, 3SBio Forge Licensing Pact for SSGJ-707 to Target Lung, Colorectal, and Gynecologic Cancers

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

BioSpace1h

Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...

Fierce Biotech1d

Pfizer pays 3SBio $1.25B for PD-1xVEGF bispecific, joining red-hot race with BioNTech, Merck

Pfizer has joined the PD-1xVEGF bispecific gold rush. The Big Pharma is paying 3SBio $1.25 billion upfront for ex-China ...

21h

Stock Movers: Home Depot, 3SBio-Pfizer, UNH

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

BioSpace22h

Pfizer Puts $6B on the Line For 3SBio’s PD-1/VEGF Antibody

The agreement comes three months after Pfizer inked a PD-1/VEGF partnership with Summit Therapeutics, leading BMO Capital ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results